StockNews.com upgraded shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a sell rating to a hold rating in a research report report published on Saturday. Separately, LADENBURG THALM/SH SH began coverage on shares of Adverum Biotechnologies in a report on Tuesday, March 7th. They set a buy rating and a $2.00 target price for […]
StockNews.com lowered shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a hold rating to a sell rating in a research report released on Friday morning. Separately, LADENBURG THALM/SH SH assumed coverage on shares of Adverum Biotechnologies in a report on Tuesday, March 7th. They set a buy rating and a $2.00 price objective on […]
Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.74 and traded as high as $0.91. Adverum Biotechnologies shares last traded at $0.91, with a volume of 295,073 shares trading hands. Wall Street Analyst […]
StockNews.com upgraded shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a sell rating to a hold rating in a research report report published on Monday. Separately, LADENBURG THALM/SH SH started coverage on Adverum Biotechnologies in a report on Tuesday, March 7th. They set a buy rating and a $2.00 target price on the stock. […]
Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Monday. Separately, LADENBURG THALM/SH SH assumed coverage on shares of Adverum Biotechnologies in a research report on Tuesday, March 7th. They set a “buy” rating and a […]